These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 321154)

  • 41. Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men.
    Pavlou SN; Interlandi JW; Wakefield G; Island DP; Rivier J; Vale W; Kovacs WJ
    J Clin Endocrinol Metab; 1987 May; 64(5):1070-4. PubMed ID: 3104387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Luteinizing hormone and follicle stimulating hormone and the response to luteinizing hormone releasing hormone in relation to sex and age.
    Lindholm J; Korsgaard O; Rasmussen P; Micic S
    Eur J Clin Invest; 1976 Jun; 6(3):249-54. PubMed ID: 780116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism.
    Weinstein RL; Reitz RE
    J Clin Invest; 1974 Feb; 53(2):408-15. PubMed ID: 11344554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Luteinizing release hormone tests in impotent diabetic males.
    Wright AD; London DR; Holder G; Williams JW; Rudd BT
    Diabetes; 1976 Oct; 25(10):975-7. PubMed ID: 789159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in plasma levels of FSH, LH and testosterone during anti-androgenic hormone therapy for patients with prostatic cancer.
    Shirai M; Matsuda S; Mitsukawa S; Nakamura M; Yonezawa K
    Tohoku J Exp Med; 1974 Oct; 114(2):145-58. PubMed ID: 4612875
    [No Abstract]   [Full Text] [Related]  

  • 47. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testicular receptors for luteinizing hormone after immunoneutralization of gonadotrophin releasing hormone in the male rat.
    Hauger RL; Kelch RP; Chen YD; Payne AH
    J Endocrinol; 1977 Oct; 75(1):23-32. PubMed ID: 200695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
    Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
    N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased 17-OH-progesterone levels following hCG stimulation in men with idiopathic oligozoospermia and raised FSH levels.
    Anapliotou ML; Liparaki M; Americanos N; Goulandris N; Papaioannou D
    Int J Androl; 1994 Aug; 17(4):192-8. PubMed ID: 7995655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An investigation into gonadal dysfunction in patients with idiopathic haemochromatosis.
    Bezwoda WR; Bothwell TH; Van Der Walt LA; Kronheim S; Pimstone BL
    Clin Endocrinol (Oxf); 1977 May; 6(5):377-85. PubMed ID: 326443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fertility after cryptorchidism: a comparative analysis of early orchidopexy with and without concomitant hormonal therapy in the young male rat.
    Friedman RM; López FJ; Tucker JA; King LR; Negro-Vilar A
    J Urol; 1994 Jan; 151(1):227-33. PubMed ID: 7902876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Male hormone--blood LH, FSH, and testosterone levels and LH-RH and HCG loading tests].
    Shimazaki J; Ito H
    Nihon Rinsho; 1979 Jun; Suppl():2595-9. PubMed ID: 385940
    [No Abstract]   [Full Text] [Related]  

  • 54. LHRH pulse frequency in normal and infertile men.
    Wu FC; Taylor PL; Sellar RE
    J Endocrinol; 1989 Oct; 123(1):149-58. PubMed ID: 2509619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The stimulatory and down-regulatory effects of a gonadotropin-releasing hormone agonist in man.
    Heber D; Bhasin S; Steiner B; Swerdloff RS
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1084-8. PubMed ID: 6233295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of the gonadotrophin-gonadal axis in androgen insensitivity syndrome.
    Ahmed SF; Cheng A; Hughes IA
    Arch Dis Child; 1999 Apr; 80(4):324-9. PubMed ID: 10086936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of gonadotrophins, testosterone, delta4 androstenedione and dihydrotesterone in idiopathic oligospermia.
    Roulier R; Mattei A; Duvivier J; Franchimont P
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):303-11. PubMed ID: 363307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inability to demonstrate an ultrashort loop feedback mechanism for luteinizing hormone in humans.
    Kyle CV; Griffin J; Jarrett A; Odell WD
    J Clin Endocrinol Metab; 1989 Jul; 69(1):170-6. PubMed ID: 2499588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal variations during sleep in men with erectile dysfunction and normal controls.
    Schiavi RC; Fisher C; White D; Beers P; Fogel M; Szechter R
    Arch Sex Behav; 1982 Jun; 11(3):189-200. PubMed ID: 6814402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restoration of the gonadotrophin response to LH-RH and oestrogen administration in patients after molar abortion.
    Miyake A; Aono T; Tanizawa O; Kurachi H; Kurachi K
    Acta Endocrinol (Copenh); 1979 May; 91(1):30-5. PubMed ID: 222100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.